The General Assembly of the AFSSI was held on April 8th. On this occasion, Anne Abot, scientific director of Enterosys, was elected to the board of directors along with representatives of two other companies: Cell&Co and Vibiosphen. Their objective is to bring their experiences and their points of view in order to enrich the strategic vision of the association and to imagine answers to the challenges of our sector.
Gut–Skin axis 2.0: why 75 % of gut disorders break out on your skin
Quick recap : what we covered last time In my first newsletter we introduced the gut–skin axis: a two-way biochemical hotline in which intestinal dysbiosis, “leaky-gut” endotoxins and microbially produced metabolites ignite cytokine storms that thin the epidermal...